Skip to main content
Log in

Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. York MR. Novel insights on the role of the innate immune system in systemic sclerosis. Expert Rev Clin Immunol 2011; 7: 481–489.

    Article  CAS  PubMed  Google Scholar 

  2. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005; 35: 548–555.

    Article  CAS  PubMed  Google Scholar 

  3. Kilpatrick DC, Stewart K, Allan EK, McLintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35: 179–181.

    Article  CAS  PubMed  Google Scholar 

  4. Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011; 21: 271–282.

    Article  CAS  PubMed  Google Scholar 

  5. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892–1896.

    CAS  PubMed  Google Scholar 

  6. Steen VD, Medsger TA Jr.. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437–2444.

    Article  CAS  PubMed  Google Scholar 

  7. Bhattacharyya S, Kelley K, Melichian DS, et al. Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses: A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma. Am J Pathol 2013; 182: 192–205.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173–1179.

    Article  CAS  PubMed  Google Scholar 

  9. Yoshizaki A, Iwata Y, Komura K, et al. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 2008; 172: 1650–1663.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Wang M, Chen Y, Zhang Y, Zhang L, Lu X, Chen Z. Mannanbinding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cell Mol Immunol 2011; 8: 265–275.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Asano.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akamata, K., Asano, Y., Aozasa, N. et al. Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype. Eur J Dermatol 24, 123–125 (2014). https://doi.org/10.1684/ejd.2013.2245

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2013.2245

Keywords

Navigation